Most doctors look at a tumor and see a disease. Professor Olivier Michielin sees a code waiting to be cracked.

Starting his career in physics and training under Nobel Prize winner Martin Karplus, Olivier realized early on that he "would not be happy just talking to electrons". He pivoted to medicine to bring a data-driven, engineering mindset to oncology. Today, he is rewriting the rules of how we treat melanoma and other complex cancers by combining immunotherapy with advanced algorithms.

In this episode, the "Tumor Hacker" joins Dr. Jurgi Camblong to discuss how he is using physics, AI, and immunotherapy to rewrite the future of oncology. From training with Nobel laureates to leading oncology at HUG, Olivier explains why the future of medicine isn’t about discovering cures by accident - it’s about engineering them by design.

A conversation about the convergence of data, biology, and the human immune system.

For more information on this episode follow the link below:

https://www.linkedin.com/in/jurgicamblong/
https://www.sophiagenetics.com/podcasts/

#Oncology #Immunotherapy #AIinHealthcare #PrecisionMedicine #DecodedPodcast

Are we practicing healthcare, or just "sick care"?

In this episode of Decoded, Jurgi Camblong sits down with Dr. Michael Snyder, Chair of Genetics at Stanford Medicine and one of the most cited scientists in the world, to challenge the status quo of modern medicine.

We monitor our cars with dashboards to prevent breakdowns, yet we wait until our bodies fail before seeking help. Dr. Snyder explains why the future of medicine isn't about treating illness—it's about predicting it.

In this episode, we cover:

The "Sick Care" Crisis: Why our current system is designed to fail and how to fix it.

The Body Dashboard: Using big data, AI, and wearables to monitor health in real-time.

Redefining Aging: How deep metabolic profiling can help us live longer, healthier lives.

The Future of Diagnostics: Moving from reactive treatments to proactive precision care.

Tune in to hear how data is rewriting the rules of human longevity.

Longevity is not luck. It is biology, variation, and human resilience expressed across generations - and we are only beginning to understand it. And few people have studied longevity more deeply than Professor Mayana Zatz, whose work with centenarians and supercentenarians is reshaping what we know about aging.

In this episode of Decoded, Dr. Jurgi Camblong speaks with one of the world’s leading geneticists and a pioneer in rare diseases, aging, and human longevity.

Based at the University of São Paulo, Mayana has followed more than 100,000 families to understand why some people develop severe genetic conditions while others remain healthy into their 90s, 100s, and beyond.

Together, they explore:

• What centenarians and supercentenarians reveal about healthy aging
• Why some individuals stay healthy despite carrying high-risk mutations
• How genetic resilience may inspire future gene therapies
• What large family cohorts teach us about rare diseases and long-term health
• The role of prevention in the next era of medicine
• Why affordability must be part of the future of genetic treatments

A conversation that brings together genetics, aging research, and the real human stories behind long life. A deeper look at what it means to live longer, and live well.

#Longevity #Genetics #Aging #Centenarians #Supercentenarians #RareDisease #HumanResilience #GeneTherapy #HealthyAging #GenomicResearch #DecodedPodcast